News

CDC: Tobacco use among teens on slow decline

BY Michael Johnsen

ATLANTA — Tobacco use among American middle school and high school students showed a slow decline from 2000 to 2011, according to a report released last week by the Centers for Disease Control and Prevention.

But when compared with other long-term studies, such as the "Youth Risk Behavior Survey," the steep rate of decline from 1997 to 2003 noticeably has slowed. CDC’s report found that in 2011 nearly 30% of high school males and 18% of high school females used some form of tobacco. More than 8% of middle school males and nearly 6% of middle school females used some form of tobacco in 2011.

Though tobacco use continued an 11-year downward trend, tobacco use remains high among high school students, the CDC said. Nearly 25% of high school males and more than 17% of high school females used some form of smoked tobacco product — cigarettes, cigars — in 2011, while smokeless tobacco use among high school males (12.9%) was eight times higher than among high school females (1.6%).

“An overall decline in tobacco use is good news, but although 4-out-of-5 teens don’t smoke, far too many kids start to smoke every day,” CDC director Thomas Frieden said. “Most tobacco use begins and becomes established during adolescence. This report is further evidence that we need to do more to prevent our nation’s youth from establishing a deadly addiction to tobacco.”

The study, “Current Tobacco Use Among Middle and High School Students — United States, 2011,” published in this week’s Morbidity and Mortality Weekly Report, reported no significant declines in the use of any tobacco product among middle school students from 2009 to 2011. However, cigarette use declined from 19.2% in 2009 to 15.8% among Hispanic high school students.

For an online version of the MMWR report, click here.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Oreo continues birthday celebration with Daily Twist campaign

BY Allison Cerra

EAST HANOVER, N.J. — Oreo is at the halfway point of its 100-day campaign that aims to illustrate moments that are making history today through the eyes of the brand.

The Oreo Daily Twist campaign creates a new digital advertisement in real-time every day that reflects the latest happenings, pop culture news, milestones or celebrations taking place in the world, Oreo said. The campaign is part of the brand’s 100-year anniversary. The campaign kicked off on June 25 and will end Oct. 2. The OREO Daily Twist marketing partners include DraftFCB (advertising), 360i (digital marketing), Weber Shandwick (public relations) and Mediavest(media).

"Oreo is all about helping people rediscover the carefree innocence of childhood," said Cindy Chen, director of marketing for Oreo at Kraft Foods. "The Daily Twist brings out the kid in all of us, no matter what your age, by giving you the chance to look at the world in a playful, more imaginative way."

keyboard_arrow_downCOMMENTS

Leave a Reply

D.DERSONE says:
Jan-29-2013 06:00 am

The best collection of wishes for all categories like birthday and anniversary,share the link to find the best collection, http://pinterest.com/williamjohn123/wishes/

TRENDING STORIES

News

FDA approves Sanofi voice-guided auto-injector for allergic reactions

BY Alaric DeArment

PARIS — The Food and Drug Administration has approved a voice-guided injection device made by Sanofi for severe allergic reactions, the drug maker said Monday.

The French drug maker announced the approval of Auvi-Q (epinephrine), calling it the first epinephrine auto-injector with audio and visual cues that guides users through the injection process. Sanofi US licensed the North American commercialization rights to Auvi-Q from Intelliject, which has retained commercialization rights for the rest of the world.

"As a company committed to patient-centered care, our focus is on creating innovative solutions that make a difference in the lives of people," Sanofi president for North American Pharmaceuticals Anne Whitaker said. "Auvi-Q delivers on this by offering a state-of-the-art epinephrine auto-injector device that addresses the needs of patients at risk for life-threatening allergic reactions and their caregivers."

 


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES